192 related articles for article (PubMed ID: 12791172)
1. Putative hAPN receptor binding sites in SARS_CoV spike protein.
Yu XJ; Luo C; Lin JC; Hao P; He YY; Guo ZM; Qin L; Su J; Liu BS; Huang Y; Nan P; Li CS; Xiong B; Luo XM; Zhao GP; Pei G; Chen KX; Shen X; Shen JH; Zou JP; He WZ; Shi TL; Zhong Y; Jiang HL; Li YX
Acta Pharmacol Sin; 2003 Jun; 24(6):481-8. PubMed ID: 12791172
[TBL] [Abstract][Full Text] [Related]
2. Putative caveolin-binding sites in SARS-CoV proteins.
Cai QC; Jiang QW; Zhao GM; Guo Q; Cao GW; Chen T
Acta Pharmacol Sin; 2003 Oct; 24(10):1051-9. PubMed ID: 14531951
[TBL] [Abstract][Full Text] [Related]
3. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.
Li F; Li W; Farzan M; Harrison SC
Science; 2005 Sep; 309(5742):1864-8. PubMed ID: 16166518
[TBL] [Abstract][Full Text] [Related]
4. Phylogenomics and bioinformatics of SARS-CoV.
Liò P; Goldman N
Trends Microbiol; 2004 Mar; 12(3):106-11. PubMed ID: 15058277
[TBL] [Abstract][Full Text] [Related]
5. Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups.
Zhang CY; Wei JF; He SH
BMC Microbiol; 2006 Oct; 6():88. PubMed ID: 17020602
[TBL] [Abstract][Full Text] [Related]
6. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.
Zhou Y; Lu K; Pfefferle S; Bertram S; Glowacka I; Drosten C; Pöhlmann S; Simmons G
J Virol; 2010 Sep; 84(17):8753-64. PubMed ID: 20573835
[TBL] [Abstract][Full Text] [Related]
7. Structural biology. Adaptation of SARS coronavirus to humans.
Holmes KV
Science; 2005 Sep; 309(5742):1822-3. PubMed ID: 16166506
[No Abstract] [Full Text] [Related]
8. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.
Madu IG; Roth SL; Belouzard S; Whittaker GR
J Virol; 2009 Aug; 83(15):7411-21. PubMed ID: 19439480
[TBL] [Abstract][Full Text] [Related]
9. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.
Petit CM; Melancon JM; Chouljenko VN; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
Virology; 2005 Oct; 341(2):215-30. PubMed ID: 16099010
[TBL] [Abstract][Full Text] [Related]
11. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction.
Lin HX; Feng Y; Wong G; Wang L; Li B; Zhao X; Li Y; Smaill F; Zhang C
J Gen Virol; 2008 Apr; 89(Pt 4):1015-1024. PubMed ID: 18343844
[TBL] [Abstract][Full Text] [Related]
12. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
[TBL] [Abstract][Full Text] [Related]
13. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
[TBL] [Abstract][Full Text] [Related]
14. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.
Li W; Zhang C; Sui J; Kuhn JH; Moore MJ; Luo S; Wong SK; Huang IC; Xu K; Vasilieva N; Murakami A; He Y; Marasco WA; Guan Y; Choe H; Farzan M
EMBO J; 2005 Apr; 24(8):1634-43. PubMed ID: 15791205
[TBL] [Abstract][Full Text] [Related]
15. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
[TBL] [Abstract][Full Text] [Related]
16. Insights from the association of SARS-CoV S-protein with its receptor, ACE2.
Li W; Choe H; Farzan M
Adv Exp Med Biol; 2006; 581():209-18. PubMed ID: 17037532
[No Abstract] [Full Text] [Related]
17. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
[TBL] [Abstract][Full Text] [Related]
18. Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C.
Breslin JJ; Mørk I; Smith MK; Vogel LK; Hemmila EM; Bonavia A; Talbot PJ; Sjöström H; Norén O; Holmes KV
J Virol; 2003 Apr; 77(7):4435-8. PubMed ID: 12634402
[TBL] [Abstract][Full Text] [Related]
19. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy.
Qu XX; Hao P; Song XJ; Jiang SM; Liu YX; Wang PG; Rao X; Song HD; Wang SY; Zuo Y; Zheng AH; Luo M; Wang HL; Deng F; Wang HZ; Hu ZH; Ding MX; Zhao GP; Deng HK
J Biol Chem; 2005 Aug; 280(33):29588-95. PubMed ID: 15980414
[TBL] [Abstract][Full Text] [Related]
20. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
